MitoRx Therapeutics is a preclinical stage biotechnology company developing first-in-class mitochondrial-targeted small molecule therapeutics aimed at addressing obesity and other cardiometabolic diseases
MitoRx Therapeutics is a preclinical stage biotechnology company developing first-in-class mitochondrial-targeted small molecule therapeutics aimed at addressing obesity and other cardiometabolic diseases. Their innovative platform focuses on modulating mitochondrial metabolism to achieve weight loss while preserving lean mass.